Silyl-mediated photoredox-catalyzed Giese reaction: addition of non-activated alkyl bromides
被引:75
作者:
ElMarrouni, Abdellatif
论文数: 0引用数: 0
h-index: 0
机构:
Merck & Co Inc, Dept Discovery Chem, MRL, 770 Sumneytown Pike, West Point, PA 19486 USAMerck & Co Inc, Dept Discovery Chem, MRL, 770 Sumneytown Pike, West Point, PA 19486 USA
ElMarrouni, Abdellatif
[1
]
Ritts, Casey B.
论文数: 0引用数: 0
h-index: 0
机构:
Merck & Co Inc, Dept Proc Res & Dev, MRL, 770 Sumneytown Pike, West Point, PA 19486 USAMerck & Co Inc, Dept Discovery Chem, MRL, 770 Sumneytown Pike, West Point, PA 19486 USA
Ritts, Casey B.
[2
]
Balsells, Jaume
论文数: 0引用数: 0
h-index: 0
机构:
Merck & Co Inc, Dept Proc Res & Dev, MRL, 770 Sumneytown Pike, West Point, PA 19486 USAMerck & Co Inc, Dept Discovery Chem, MRL, 770 Sumneytown Pike, West Point, PA 19486 USA
Balsells, Jaume
[2
]
机构:
[1] Merck & Co Inc, Dept Discovery Chem, MRL, 770 Sumneytown Pike, West Point, PA 19486 USA
[2] Merck & Co Inc, Dept Proc Res & Dev, MRL, 770 Sumneytown Pike, West Point, PA 19486 USA
The emergence of photoredox catalysis has enabled the discovery of mild and efficient conditions for the generation of a variety of radical reaction platforms. Herein is disclosed the development of a conjugate addition reaction of non-activated alkyl bromides to Michael acceptors under visible-light photoredox catalysis. Optimization of the reaction was achieved using high-throughput experimentation (HTE) tools to enable the identification of mild, general and practical reaction conditions. A diverse set of alkyl bromides was successfully added to cyclic or acyclic alpha,beta-unsaturated esters and amides. The features of this transformation allowed also access to a key intermediate of Vorinostat (R), an HDAC inhibitor used to fight cancer and HIV.